(Q40111282)

17 September 2017

Relation of Herpes Simplex Viruses to Human Malignancies (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

31 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200405

31 December 2022

author name string

W. E. Rawls

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200405

31 December 2022

S. Bacchetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200405

31 December 2022

F. L. Graham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A200405

31 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=200405

31 December 2022

publication date

1 January 1977

1 reference

full work available at URL

17 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-642-66740-4_3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Current Topics in Microbiology and Immunology

31 December 2022

published in

1 reference

17 September 2017

77

1 reference

17 September 2017

71-95

1 reference

Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria

17 September 2017

5

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency.

31 December 2022

8

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma

31 December 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

IgM Antibody to a Tumor-Associated Antigen (AG-4) Induced by Herpes Simplex Virus Type 2: Its Use in Location of the Antigen in Infected Cells 2

31 December 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA

31 December 2022

12

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Evidence for persistence of infectious agents in isolated human populations.

31 December 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Experimental human reinfection with herpes simplex virus

31 December 2022

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Transformation of mouse cells after infection with ultraviolet irradiation-inactivated herpes simplex virus type 2

31 December 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Presence of herpes simplex virus-related antigens in transformed L cells

31 December 2022

18

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of herpes simplex virus infected cells

31 December 2022

19

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Human embryonic lung cells abortively infected with Herpes virus hominis type 2 show some properties of cell transformation

31 December 2022

22

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2.

31 December 2022

25

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Quantitative assay for transformation of 3T3 cells by herpes simplex virus type 2

31 December 2022

27

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Comparative pathology of cells transformed by herpes simplex virus type 1 or type 2.

31 December 2022

28

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Epstein-Barr Virus — Is It Time To Develop a Vaccine Program?

31 December 2022

29

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue

31 December 2022

31

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpes simplex virus DNA in transformed cells: sequence complexity in five hamster cell lines and one derived hamster tumor

31 December 2022

32

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

A new technique for the assay of infectivity of human adenovirus 5 DNA

31 December 2022

33

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Infectious herpesvirus DNA

31 December 2022

34

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Size and location of the transforming region in human adenovirus type 5 DNA

31 December 2022

35

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Activation of an endogenous mouse type C virus by ultraviolet-irradiated herpes simplex virus types 1 and 2

31 December 2022

37

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Induction of deoxyribonucleic acid polymerase and deoxyribonuclease activities in cells infected with herpes simplex virus type II.

31 December 2022

38

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites

31 December 2022

39

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components

31 December 2022

40

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.

31 December 2022

42

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Antibodies to Herpesvirus Nonvirion Antigens in Squamous Carcinomas

31 December 2022

43

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens

31 December 2022

44

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Oncogenes of RNA tumor viruses as determinants of cancer

31 December 2022

47

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation

31 December 2022

48

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

31 December 2022

49

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia

31 December 2022

50

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Oncogenic transformation of primary hamster cells by herpes simplex virus type 2 (HSV-2) and an HSV-2 temperature-sensitive mutant

31 December 2022

56

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus

31 December 2022

60

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Demonstration of oncogenic potential of mammalian cells transformed by dna-containing viruses following photodynamic inactivation

31 December 2022

61

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

31 December 2022

62

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Differences in thymidine kinase-inducing ability of herpesvirus types 1 and 2

31 December 2022

63

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Transformation of rat embryo cells by temperature-sensitive mutants of herpes simplex virus

31 December 2022

64

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Complementation of ts mutants by a herpes simplex virus ts-transformed cell line

31 December 2022

66

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

31 December 2022

Virus-associated enzymes

67

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2

31 December 2022

68

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia

31 December 2022

69

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Antibodies to Herpes Simplex Virus in Jewish Women With Cervical Cancer and in Healthy Jewish Women of Israel2

31 December 2022

71

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer.

31 December 2022

76

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Sarcomas after inoculation of newborn hamsters with Herpes virus hominis type 2 strains.

31 December 2022

77

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Infection with herpes-simplex viruses 1 and 2. 3.

31 December 2022

79

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

The epidemiology and interrelationship of cervical dysplasia and type 2 herpesvirus in a low-income housing project

31 December 2022

86

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Diseases and Mechanisms of Persistent DNA Virus Infection: Latency and Cellular Transformation

31 December 2022

87

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpesvirus Antibodies and Antigens in Patients With Cervical Anaplasia and in Controls 2

31 December 2022

89

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Antibodies to Herpesvirus Hominis Types 1 and 2 Among Women with Neoplastic Change of Uterine Cervix

31 December 2022

90

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

STUDY OF VIRULENCE AND TUMORIGENICITY OF VARIANTS OF HERPES SIMPLEX VIRUS.

31 December 2022

93

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation

31 December 2022

95

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

31 December 2022

Herpesviruses and cancer

96

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

The association of herpesvirus type 2 and carcinoma of the uterine cervix

31 December 2022

98

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

The association of genital herpesvirus with cervical atypia and carcinoma in situ

31 December 2022

104

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma

31 December 2022

105

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpes simplex and herpes genitalis viruses in etiology of some human cancers

31 December 2022

106

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpes simplex-genitalis virus nonvirion antigens and their implication in certain human cancers: unconfirmed

31 December 2022

107

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Antigenic differences between isolates of herpesvirus type 2.

31 December 2022

110

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Structure and function of herpesvirus genomes. I. comparison of five HSV-1 and two HSV-2 strains by cleavage their DNA with eco R I restriction endonuclease

31 December 2022

113

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Precipitating antibodies to herpes simplex virus in human sera: prevalence of antibody to common antigen (band II).

31 December 2022

115

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Herpesvirus type 2 infection and carcinoma of the cerivix.

31 December 2022

117

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia

31 December 2022

118

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2.

31 December 2022

120

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus

31 December 2022

122

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus

31 December 2022

124

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses

31 December 2022

128

1 reference

https://api.crossref.org/works/10.1007/978-3-642-66740-4_3

31 December 2022

Identifiers

0 references

1 reference